T
48
3
BMY
61
-3
DFS
67
-3
KSS
42
-3
SYY
47
-2
DGX
48
-3
SRE
66
-3
KHC
17
4
PX
73
-6
CMS
58
-2
MU
32
-6
CNP
50
-2
URBN
66
2
GLW
48
-5
VNO
60
8
PWR
71
-3
XRX
34
-3
UA
57
4
ADM
24
2
CHRW
67
3
T
48
3
BMY
61
-3
DFS
67
-3
KSS
42
-3
SYY
47
-2
DGX
48
-3
SRE
66
-3
KHC
17
4
PX
73
-6
CMS
58
-2
MU
32
-6
CNP
50
-2
URBN
66
2
GLW
48
-5
VNO
60
8
PWR
71
-3
XRX
34
-3
UA
57
4
ADM
24
2
CHRW
67
3
Financhill
Back

The Oncology Institute 10K Form

Sell
25

TOI
The Oncology Institute

Last Price:
0.24
Seasonality Move:
-18.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.24M
Cash Flow: $-17.49M
Price / Cash Flow: 0
Annual Sales: $0.39
Price / Book: 0.74

Profitability

EPS (TTM): -0.79000
Net Income (TTM): $-71.54M
Gross Margin: $59.57M
Return on Equity: -125.91%
Return on Assets: -34.34%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 3.08
Current Ratio: 3.31
Quick Ratio: 2.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
25
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?